ProstaNorm, 200 mg 30 pcs

The drug has a pronounced prostatropic effect due to anti-inflammatory, analgesic, bacteriostatic (staphylococci, enterococci) effect.

ProstaNorm® improves microcirculation of prostate tissues, ejaculate parameters (including sperm motility) at pathoospermia and prostate secretion due to chronic prostatitis; normalizes urination.

Indications

Chronic prostatitis, infertility (pathozoospermia) due to chronic prostatitis (in complex therapy), anti-inflammatory and urinary normalizing agent.

Pharmacological effect

The drug has a pronounced prostatotropic effect due to anti-inflammatory, analgesic, bacteriostatic (staphylococci, enterococci) effect.

ProstaNorm® improves microcirculation of prostate tissue, ejaculate parameters (including sperm motility) with pathozoospermia and prostate secretion due to chronic prostatitis; normalizes urination.

Special instructions

The use of the drug does not affect the ability to perform potentially hazardous activities that require increased concentration of attention and speed of psychomotor reactions (driving vehicles, working with moving mechanisms, working as a dispatcher and operator

Active ingredient

Licorice root, Goldenrod herb, St. John’s wort herb, Echinacea purpurea rhizome with roots

Composition

Dry extract (obtained from a mixture of medicinal plant materials: St. John’s wort herb, Canadian goldenrod herb, licorice roots, Echinacea purpurea rhizomes with roots (1:1:1:1), containing the sum of flavonoids in terms of rutin 5%) – 200 mg.

Excipients:

potato starch – 40.00 mg;

lactose – 149.98 mg;

povidone K-30 – 4.00 mg;

colloidal silicon dioxide –2.02 mg;

magnesium stearate – 4.00 mg.

Contraindications

Hypersensitivity to the components of the drug, acute glomerulonephritis, galactose and/or fructose intolerance, lactase and/or sucrase/isomaltase deficiency, glucose-galactose malabsorption.

With caution: for diseases for which the use of immunostimulating agents is not recommended (the drug contains echinacea extract).

The effectiveness and safety of ProstaNorma® in persons under 18 years of age has not been studied.

Side Effects

Allergic reactions are possible.

Interaction

No incompatibility with drugs from other groups has been identified.

Treatment can be combined with the use of biogenic stimulants, vitamins, antibacterial drugs, prostate massage and physiotherapeutic procedures.

Overdose

To date, there have been no reports of cases of overdose when using the drug.

Storage conditions

At a temperature not exceeding 25 °C, in the original packaging. Keep out of the reach of children.

Shelf life

5 years. Do not use after the expiration date stated on the package.

Manufacturer

PharmVilar NPO LLC, Russia